Hepion Pharmaceuticals Stock Price History
| HEPA Stock | USD 1.32 0.17 11.41% |
Below is the normalized historical share price chart for Hepion Pharmaceuticals extending back to February 10, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Hepion Pharmaceuticals stands at 1.32, as last reported on the 24th of April, with the highest price reaching 1.54 and the lowest price hitting 1.30 during the day.
If you're considering investing in Hepion Stock, it is important to understand the factors that can impact its price. Hepion Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0282, which attests that the entity had a -0.0282% return per unit of risk over the last 3 months. Hepion Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Hepion Pharmaceuticals' Risk Adjusted Performance of (0.01), standard deviation of 8.4, and Market Risk Adjusted Performance of (1.01) to validate the risk estimate we provide.
At present, Hepion Pharmaceuticals' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 4.2 M, whereas Total Stockholder Equity is forecasted to decline to about 6.9 M. . At present, Hepion Pharmaceuticals' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 1.86, whereas Price Earnings Ratio is forecasted to decline to (0.28). Hepion Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of February 2014 | 200 Day MA 4.2297 | 50 Day MA 2.3058 | Beta 1.616 |
Hepion |
Sharpe Ratio = -0.0282
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HEPA |
Estimated Market Risk
| 8.69 actual daily | 76 76% of assets are less volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Hepion Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hepion Pharmaceuticals by adding Hepion Pharmaceuticals to a well-diversified portfolio.
Price Book 0.6748 | Book Value 1.159 | Enterprise Value -4.7 M | Enterprise Value Ebitda 0.1542 | Shares Float 5 M |
Hepion Pharmaceuticals Stock Price History Chart
There are several ways to analyze Hepion Stock price data. The simplest method is using a basic Hepion candlestick price chart, which shows Hepion Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 1, 2024 | 3.17 |
| Lowest Price | April 24, 2024 | 1.32 |
Hepion Pharmaceuticals April 24, 2024 Stock Price Synopsis
Various analyses of Hepion Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Hepion Stock. It can be used to describe the percentage change in the price of Hepion Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Hepion Stock.| Hepion Pharmaceuticals Price Daily Balance Of Power | (0.71) | |
| Hepion Pharmaceuticals Price Rate Of Daily Change | 0.89 | |
| Hepion Pharmaceuticals Price Action Indicator | (0.18) | |
| Hepion Pharmaceuticals Accumulation Distribution | 5,868 |
Hepion Pharmaceuticals April 24, 2024 Stock Price Analysis
Hepion Stock Price History Data
The price series of Hepion Pharmaceuticals for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 has a statistical range of 1.76 with a coefficient of variation of 17.14. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.18. The median price for the last 90 days is 2.24. The company completed 1:20 stock split on 11th of May 2023. Hepion Pharmaceuticals completed dividends distribution on 2019-06-03.| Open | High | Low | Close | Volume | ||
| 04/24/2024 | 1.52 | 1.54 | 1.30 | 1.32 | 37,656 | |
| 04/23/2024 | 1.38 | 1.52 | 1.29 | 1.49 | 70,800 | |
| 04/22/2024 | 1.22 | 1.60 | 1.22 | 1.41 | 322,305 | |
| 04/19/2024 | 2.13 | 2.20 | 2.01 | 2.01 | 132,514 | |
| 04/18/2024 | 2.10 | 2.21 | 2.04 | 2.11 | 29,949 | |
| 04/17/2024 | 2.05 | 2.21 | 2.00 | 2.13 | 21,542 | |
| 04/16/2024 | 2.14 | 2.24 | 2.04 | 2.04 | 25,712 | |
| 04/15/2024 | 2.24 | 2.35 | 2.16 | 2.18 | 10,027 | |
| 04/12/2024 | 2.22 | 2.30 | 2.18 | 2.19 | 16,941 | |
| 04/11/2024 | 2.35 | 2.35 | 2.08 | 2.23 | 34,462 | |
| 04/10/2024 | 2.46 | 2.46 | 2.22 | 2.28 | 35,155 | |
| 04/09/2024 | 2.52 | 2.56 | 2.38 | 2.44 | 17,724 | |
| 04/08/2024 | 2.49 | 2.61 | 2.47 | 2.56 | 16,226 | |
| 04/05/2024 | 2.61 | 2.64 | 2.49 | 2.52 | 29,976 | |
| 04/04/2024 | 2.55 | 2.90 | 2.41 | 2.64 | 122,310 | |
| 04/03/2024 | 2.25 | 2.56 | 2.25 | 2.56 | 45,522 | |
| 04/02/2024 | 2.39 | 2.39 | 2.22 | 2.29 | 26,580 | |
| 04/01/2024 | 2.44 | 2.45 | 2.31 | 2.36 | 39,583 | |
| 03/28/2024 | 2.47 | 2.53 | 2.42 | 2.49 | 21,291 | |
| 03/27/2024 | 2.30 | 2.56 | 2.22 | 2.50 | 51,687 | |
| 03/26/2024 | 2.25 | 2.41 | 2.25 | 2.32 | 32,817 | |
| 03/25/2024 | 2.28 | 2.37 | 2.21 | 2.25 | 8,445 | |
| 03/22/2024 | 2.32 | 2.42 | 2.05 | 2.35 | 25,902 | |
| 03/21/2024 | 2.21 | 2.34 | 2.20 | 2.32 | 14,562 | |
| 03/20/2024 | 2.11 | 2.35 | 2.05 | 2.34 | 12,473 | |
| 03/19/2024 | 2.20 | 2.29 | 2.07 | 2.13 | 24,851 | |
| 03/18/2024 | 2.07 | 2.21 | 2.07 | 2.18 | 45,789 | |
| 03/15/2024 | 2.20 | 2.36 | 1.96 | 2.26 | 40,719 | |
| 03/14/2024 | 2.07 | 2.31 | 1.89 | 2.04 | 50,387 | |
| 03/13/2024 | 2.12 | 2.44 | 2.02 | 2.09 | 74,556 | |
| 03/12/2024 | 2.23 | 2.24 | 2.08 | 2.18 | 28,723 | |
| 03/11/2024 | 2.30 | 2.38 | 2.15 | 2.24 | 25,336 | |
| 03/08/2024 | 2.55 | 2.55 | 2.25 | 2.35 | 45,603 | |
| 03/07/2024 | 2.43 | 2.43 | 2.22 | 2.26 | 28,317 | |
| 03/06/2024 | 2.57 | 2.68 | 2.16 | 2.29 | 107,039 | |
| 03/05/2024 | 2.83 | 2.93 | 2.52 | 2.60 | 60,869 | |
| 03/04/2024 | 3.00 | 3.24 | 2.83 | 2.83 | 50,155 | |
| 03/01/2024 | 3.18 | 3.33 | 3.00 | 3.17 | 93,830 | |
| 02/29/2024 | 2.79 | 3.10 | 2.76 | 2.97 | 70,903 | |
| 02/28/2024 | 2.42 | 2.82 | 2.34 | 2.76 | 105,463 | |
| 02/27/2024 | 2.42 | 2.48 | 2.28 | 2.39 | 57,372 | |
| 02/26/2024 | 2.42 | 2.59 | 2.26 | 2.34 | 45,202 | |
| 02/23/2024 | 2.45 | 2.59 | 2.30 | 2.42 | 99,946 | |
| 02/22/2024 | 2.28 | 2.60 | 2.17 | 2.45 | 75,230 | |
| 02/21/2024 | 2.47 | 2.47 | 2.06 | 2.27 | 53,939 | |
| 02/20/2024 | 3.05 | 3.05 | 2.33 | 2.48 | 54,697 | |
| 02/16/2024 | 2.29 | 3.49 | 2.04 | 2.56 | 427,133 | |
| 02/15/2024 | 1.94 | 2.95 | 1.93 | 2.70 | 623,541 | |
| 02/14/2024 | 1.82 | 2.07 | 1.82 | 1.98 | 148,198 | |
| 02/13/2024 | 1.53 | 2.27 | 1.53 | 1.82 | 471,730 | |
| 02/12/2024 | 1.56 | 1.59 | 1.50 | 1.52 | 43,968 | |
| 02/09/2024 | 1.50 | 1.61 | 1.49 | 1.52 | 49,823 | |
| 02/08/2024 | 1.56 | 1.61 | 1.51 | 1.51 | 110,348 | |
| 02/07/2024 | 1.59 | 1.59 | 1.51 | 1.56 | 36,261 | |
| 02/06/2024 | 1.68 | 1.70 | 1.50 | 1.58 | 143,156 | |
| 02/05/2024 | 1.68 | 1.70 | 1.60 | 1.65 | 35,258 | |
| 02/02/2024 | 1.72 | 1.75 | 1.62 | 1.66 | 59,698 | |
| 02/01/2024 | 1.85 | 2.01 | 1.66 | 1.69 | 163,820 | |
| 01/31/2024 | 1.82 | 2.08 | 1.72 | 1.90 | 58,794 | |
| 01/30/2024 | 1.84 | 1.85 | 1.74 | 1.79 | 37,820 | |
| 01/29/2024 | 1.91 | 1.91 | 1.79 | 1.84 | 48,347 |
About Hepion Pharmaceuticals Stock history
Hepion Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Hepion is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Hepion Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Hepion Pharmaceuticals stock prices may prove useful in developing a viable investing in Hepion Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4 M | 4.2 M | |
| Net Loss | -40.8 M | -38.8 M |
Hepion Pharmaceuticals Quarterly Net Working Capital |
|
Hepion Pharmaceuticals Stock Technical Analysis
Hepion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Hepion Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Hepion Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Hepion Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Hepion to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (1.36) | |||
| Treynor Ratio | (1.02) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Hepion Stock analysis
When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Hepion Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.32) | Return On Assets (0.72) | Return On Equity (1.71) |
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.